Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Down's syndrome, cardiac anomalies, and nuchal translucency.

Literature DB >> 9880259

Down's syndrome, cardiac anomalies, and nuchal translucency.

B W Mol.

Abstract

Entities: Disease

Mesh：

Year: 1999 PMID： 9880259 PMCID： PMC1114607 DOI： 10.1136/bmj.318.7176.70

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

11 in total

1. Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older.

Authors: M C Macintosh; N J Wald; T Chard; J Hansen; M Mikkelsen; A J Therkelsen; G B Petersen; C Lundsteen
Journal: Br J Obstet Gynaecol Date: 1995-10

2. Antenatal screening for Down's syndrome: where are we and where next?

Authors: J E Haddow
Journal: Lancet Date: 1998-08-01 Impact factor: 79.321

3. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

Authors: J Hyett; M Perdu; G Sharland; R Snijders; K H Nicolaides
Journal: BMJ Date: 1999-01-09

4. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.

Authors: J A Hyett; N J Sebire; R J Snijders; K H Nicolaides
Journal: Ultrasound Obstet Gynecol Date: 1996-02 Impact factor: 7.299

5. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.

Authors: B W Mol; E Pajkrt; J J van Lith; C M Bilardo
Journal: Br J Obstet Gynaecol Date: 1996-10

6. Assessment of fetal nuchal translucency test for Down's syndrome.

Authors: J P Neilson
Journal: Lancet Date: 1997-09-13 Impact factor: 79.321

7. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.

Authors: K H Nicolaides; M L Brizot; R J Snijders
Journal: Br J Obstet Gynaecol Date: 1994-09

8. Increased nuchal translucency as a marker for fetal chromosomal defects.

Authors: P Taipale; V Hiilesmaa; R Salonen; P Ylöstalo
Journal: N Engl J Med Date: 1997-12-04 Impact factor: 91.245

9. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.

Authors: R J Snijders; P Noble; N Sebire; A Souka; K H Nicolaides
Journal: Lancet Date: 1998-08-01 Impact factor: 79.321